Answers are grounded in this paper and cite their sources.
Gold (AuNPs) and silver nanoparticles (AgNPs) have attracted considerable interest in biomedical applications, including imaging, diagnostics, targeted drug delivery, and cancer theranostics, owing to their distinctive physicochemical properties. However, their expanding use in medical, industrial, and consumer products has raised concerns regarding their biological safety. This review critically examines the mechanisms underlying AuNP and AgNP toxicity in vitro and in vivo, with emphasis on the influence of particle size, shape, surface chemistry, functionalization, and exposure conditions on their biological interactions and toxicological profiles. Key mechanisms include oxidative stress, mitochondrial dysfunction, genotoxicity, inflammatory and immune responses, and the induction of apoptosis or necrosis. Particular attention is given to the role of silver-ion release in AgNP-induced toxicity and to the formulation-dependent effects of AuNPs, which, despite their generally greater chemical stability, cannot be considered inherently harmless. The review also discusses biodistribution, organ-specific effects, human exposure, and current limitations in toxicological assessment, highlighting the need for standardized testing protocols and comprehensive dose- and exposure-dependent evaluations. Finally, emerging safe-by-design strategies and advanced assessment approaches are explored to support the rational development of safer metallic nanomaterials for biomedical and consumer applications.
No takes yet. Share an insight, caveat, or question.
Efthimiadou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: